http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011530494-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-20 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-38 |
| filingDate | 2009-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011530494-A |
| titleOfInvention | Stereoselective preparation of bicyclic heterocycles |
| abstract | A method for stereoselectively preparing the quinazoline derivative of the present invention is provided. A compound of the general formula (I) or a salt thereof having an inhibitory action on effective pharmacological properties, in particular signal transduction mediated by tyrosine kinases, in particular inorganic acids or inorganic bases or organic acids or organic bases The physiologically compatible salt containing is stereoselectively produced. Used in the treatment of diseases, especially tumor diseases, benign prostatic hypertrophy (BPH), lung and respiratory diseases. [Chemical 1] (I) (II) (VIII) [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013501025-A |
| priorityDate | 2008-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.